Autolus Therapeutics (AUTL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov12

Autolus Therapeutics Reports Strong Q3 2025 Financials and Positive CAR T Therapy Clinical Data

16:33

Autolus Therapeutics released FY2025 Q3 earnings on November 12 Pre-Market (EST), actual revenue USD 21.19 M (forecast USD 21.31 M), actual EPS USD -0.2972 (forecast USD -0.2208)

14:30

Autolus Therapeutics released FY2025 9 Months Earnings on November 12 Pre-Market EST, with actual revenue of USD 51.1 M and EPS of USD -0.7436

14:30

Nov5

Autolus Therapeutics to Release FY2025 Q3 Earnings on November 12 Pre-Market EST, Forecast Revenue USD 21.31 M, EPS USD -0.229

00:20

Oct20

Gil Blum gives Autolus Therapeutics a Buy Rating

10:06

Aug12

Autolus Therapeutics released FY2025 Semi-Annual Earnings on August 12 Pre-Market EST, with actual revenue of USD 29.91 M and EPS of USD -0.4436

13:30

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 21.19 M, Net Income -79.12 M, EPS -0.2972

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 20.92 M, Net Income -47.92 M, EPS -0.18

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 8.982 M, Net Income -70.16 M, EPS -0.2636

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change